[ad_1]
- Relay Therapeutics (NASDAQ:RLAY) on Monday mentioned it has commenced an underwritten public offering of $200 million of shares of its common stock.
- Relay Therapeutics additionally intends to grant the underwriters a 30-day choice to buy as much as an extra 15% of the shares of common stock provided within the public offering.
- RLAY -6.41% after hours to $8.9.
- Source: Press Release
More on Relay Therapeutics
[ad_2]
Source: Seekingalpha